Laboratório de Biomecânica (BIOMEC), Centro de Desportos, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
Programa de Pós-Graduação em Ciências do Movimento, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil.
Photobiomodul Photomed Laser Surg. 2020 Dec;38(12):734-742. doi: 10.1089/photob.2019.4785. Epub 2020 Nov 23.
The aims of this study were to verify the effects of photobiomodulation therapy (PBMT) on time trial run performance over 1500 m, as well as on individual responsiveness of recreative runners. Nineteen recreationally trained runners participated in a randomized, crossover, double-blind placebo-controlled trial. The study was divided in four sessions: (1) incremental maximal running test; (2) 1500 m run control (without placebo or PBMT); and (3, 4) PBMT or placebo before 1500 m run. PBMT or placebo was applied over 14 sites per lower limb immediately before time trial run using a mixed wavelength device (33 diodes: 5 LASERs of 850 nm, 12 LEDs of 670 nm, 8 LEDs of 880 nm, and 8 LEDs with 950 nm). PBMT delivered 30 J per site, with a total energy dose of 840 J. Physiological variables [maximal oxygen uptake (VO), velocity associated to VO (vVO), peak of velocity, and respiratory compensation point (RCP)] were assessed during incremental maximal test. During 1500 m races we accessed the following: time, heart rate, and lower limb rate perception exertion per lap, total time, and blood lactate concentration ([Lac]). PBMT had no significant difference and likely trivial effect for performance in the total time trial run over 1500 m compared to placebo. In the responsiveness analyses, 10 participants positively responded to PBMT, whereas total time reduced for responders (-10.6 sec; -3.18%) and increased for nonresponders (+6.0 sec; +1.73%). Responders presented higher aerobic parameters (VO and RCP) than nonresponders. Moreover, responders had lower time per lap and [Lac] (1 and 3 min) when PBMT was applied. PBMT applied immediately before running in noncontrolled environment was not able to improve the 1500 m performance of recreationally trained runners. However, responders to PBMT presented higher aerobic capacity than nonresponders.
本研究旨在验证光生物调节疗法(PBMT)对 1500 米计时跑表现的影响,以及对休闲跑者个体反应的影响。19 名接受过训练的休闲跑者参与了一项随机、交叉、双盲安慰剂对照试验。研究分为四个阶段:(1)递增最大跑步测试;(2)1500 米跑步控制(无安慰剂或 PBMT);以及(3、4)PBMT 或安慰剂在 1500 米跑步前。在计时跑前,使用混合波长设备(33 个二极管:5 个 850nm 的 LASER,12 个 670nm 的 LED,8 个 880nm 的 LED 和 8 个 950nm 的带 LED)在每个下肢的 14 个部位施加 PBMT 或安慰剂。每个部位的 PBMT 剂量为 30J,总能量剂量为 840J。在递增最大测试中评估生理变量[最大摄氧量(VO)、与 VO 相关的速度(vVO)、速度峰值和呼吸补偿点(RCP)]。在 1500 米比赛中,我们记录了以下数据:时间、心率、每圈下肢感知的用力程度、总时间和血乳酸浓度([Lac])。与安慰剂相比,PBMT 对 1500 米计时跑的总时间表现没有显著差异,且可能具有微小影响。在反应性分析中,有 10 名参与者对 PBMT 有积极反应,而对响应者的总时间减少了(-10.6 秒;-3.18%),对非响应者的总时间增加了(+6.0 秒;+1.73%)。响应者的有氧参数(VO 和 RCP)高于非响应者。此外,当应用 PBMT 时,响应者的每圈时间和 [Lac](1 和 3 分钟)更低。在非受控环境下,在跑步前立即应用 PBMT 不能提高休闲跑者的 1500 米表现。然而,对 PBMT 有反应的人比没有反应的人具有更高的有氧能力。